Aberrant expression of multiple γ-glutamyltransferases is associated with tumor progression and patient outcome in prostate cancers
Our data suggests that GGT6 is a new AR downstream target but GGT7 is a potential NEPC biomarker.
Authors
- Xiangwei Wang (ORCID: https://orcid.org/0000-0001-8108-4979)
- Benyi Li (ORCID: https://orcid.org/0000-0001-6242-5117)
- Wang Liu (ORCID: https://orcid.org/0009-0001-5856-6774)
- Ming Xi (ORCID: https://orcid.org/0000-0002-6296-0440)
- Jiang Zhao (ORCID: https://orcid.org/0000-0002-7588-9612)
- Wencong Jiang
- Zhijian Xu
Institutions
- Guangdong Medical College (CN)
- University of Kansas Medical Center (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-28
- DOI
- https://doi.org/10.3389/fonc.2025.1518636
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00